TGFB1 and type 2 diabetes mellitus: Analysis of the TGF‐β1 circulating levels in serum of patients from the MONICA/KORA case cohort, showed that the concentration of the TGF‐β1 ligand in the serum between patients with T2DM and without T2DM did not differ when all patients were summarized together.